Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb:115:154434.
doi: 10.1016/j.metabol.2020.154434. Epub 2020 Nov 17.

Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence

Joost Smolders  1 , Jody van den Ouweland  2 , Christopher Geven  3 , Peter Pickkers  3 , Matthijs Kox  4
Affiliations
Comment

Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence

Joost Smolders et al. Metabolism. 2021 Feb.
No abstract available

Keywords: COVID-19; Coronavirus; Cytokines; Inflammation; SARS-CoV-2; Vitamin D.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1
Fig. 1
Plasma 25(OH)D levels (panel A) and cytokine concentrations (panel B) in response to LPS infusion in healthy volunteers. In panel A, data are depicted as individual datapoints and corresponding box-plots (whiskers: min-max), and dashed lines indicate median values at baseline (T = 0) and nadir (T = 2 and T = 3). P-value was calculated using Friedman test. *p < 0.05 vs. baseline, calculated using Dunn's post-hoc test. In panel B, data are presented as mean and SEM. Data of 9 subjects are shown in both panels.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Chakhtoura M., Napoli N., El Hajj Fuleihan G. Commentary: myths and facts on vitamin D amidst the COVID-19 pandemic. Metabolism. 2020;109:154276. doi: 10.1016/j.metabol.2020.154276. - DOI - PMC - PubMed
    1. Kox M., Waalders N.J.B., Kooistra E.J., Gerretsen J., Pickkers P. Cytokine levels in critically ill patients with COVID-19 and other conditions. JAMA - J Am Med Assoc. 2020;324(15):E1–E3. doi: 10.1001/jama.2020.17052. - DOI - PMC - PubMed
    1. Pizzini A., Aichner M., Sahanic S. Impact of vitamin d deficiency on covid-19—a prospective analysis from the covild registry. Nutrients. 2020;12(9):1–9. doi: 10.3390/nu12092775. - DOI - PMC - PubMed
    1. Hastie C.E., Mackay D.F., Ho F. Vitamin D concentrations and COVID-19 infection in UK biobank. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):561–565. doi: 10.1016/j.dsx.2020.04.050. - DOI - PMC - PubMed
    1. Geven C., van Lier D., Blet A. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects. Br J Clin Pharmacol. 2018;84(9):2129–2141. doi: 10.1111/bcp.13655. - DOI - PMC - PubMed